PodcastIntel
Sign in Get Started Free
Science, Spoken
Science, Spoken

The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival

Nov 10, 2023 · 7m
Listen to Episode
✨ AI Summary
  • FDA approves Zepbound, a new weight loss drug.
  • Eli Lilly enters competitive market for obesity treatments.
  • Rival to existing blockbuster drugs like Wegovy and Ozempic.

More from Science, Spoken

Science, Spoken
From The Big Story: The Internet Runs on Cats and Porn. It’s About to Get Cattier and Pornier
Oct 11, 2026 · 33m
Science, Spoken
From The Big Story: Billions Registered
Oct 9, 2026 · 29m
Science, Spoken
From The Big Story: Why the Future Doesn't Need Us
Oct 7, 2026 · 1h 18m
Science, Spoken
From The Big Story: Choke Points
Oct 4, 2026 · 36m
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Science, Spoken and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →